Douglas Crawford’s goal is to help entrepreneurial scientists create successful startups. To this end, Doug and his colleagues have systematically lowered the barriers between great ideas and successful companies. For instance, Crawford created and manages QB3@953.
This state-of-the-art co-working laboratory program in San Francisco allows entrepreneurs to rapidly generate data without getting bogged down in facility management. Rather than spending months getting a facility up and running, QB3@953 startups can generate important data in their first week.
In the first 3 years, this program has helped launch 94 companies that have raised over 1.36B. This incubator program reflects Doug’s passion for startups and his eagerness to help entrepreneurs overcome challenges.
Doug is also the Managing Director of Mission Bay Capital and has overseen the investment in 34 companies, 4 of which have already enjoyed successful exits (Calithera, iPierian, Redwood Biosciences and Zephyrus). He is a board member of Avexegen, Circle Pharma, Delpor, Invenio, Magnamosis, Magnap, SiteOne (observer), Tangible Sciences, and Viewpoint.
Crawford received his PhD in biochemistry from UCSF. Loves traveling with his family, making great pizza, and killer cappuccinos.